Estrogen Receptor Mutations in HR+ Advanced Breast Cancer: Next-Generation Practice Recommendations on Mutation Screening to Guide Therapeutic Decisions

Deepen your understanding of estrogen receptor 1 (ESR1) mutations in HR+ advanced breast cancer by exploring best practices on advanced breast cancer mutation screening. Download summary slides with key data from the live symposium, listen to the expert’s podcast, and rewatch the live event with an on-demand webcast.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca and Lilly

AstraZeneca

Lilly